カテゴリー： 世界, 医療/バイオ, LP Information

世界の血管性認知症治療市場予測 2023年-2029年

【英語タイトル】Global Vascular Dementia Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08715）・商品コード：LP23DC08715
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の血管性認知症治療市場」は、過去の販売実績から2022年の世界の血管性認知症治療の総販売量を検討し、2023年から2029年の予測される血管性認知症治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の血管性認知症治療の市場規模を掲載し、XXX百万米ドル規模の世界の血管性認知症治療市場の詳細な分析を提供します。本インサイトレポートは、世界の血管性認知症治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の血管性認知症治療市場における各社の独自のポジションをより深く理解するために、血管性認知症治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の血管性認知症治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。血管性認知症治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。血管性認知症治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。血管性認知症治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

血管性認知症治療の世界主要メーカーとしては、Eisai、 Pfizer、 Teva、 Novartis、 Apotex、 Dr Reddy's Laboratories、 Sun Pharmaceutical、 Hansoh Pharma、 Cipla、 BCG Matrix、 PESTLE Analysis、 SWOT Analysis、 Porter’s five forces、 Market Entry Strategies, Inc.、 Ever Neuro Pharma GmbH、 Geny Research Corp.、 Johnson & Johnsonなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の血管性認知症治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では血管性認知症治療市場をセグメンテーションし、種類別 (治療、機器介入)、用途別 (病院、診療所、リハビリセンター、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：治療、機器介入

・用途別区分：病院、診療所、リハビリセンター、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の血管性認知症治療市場の10年間の市場状況・展望は？
・世界および地域別に見た血管性認知症治療市場成長の要因は何か？
・血管性認知症治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・血管性認知症治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：血管性認知症治療の年間販売量2018-2029、地域別現状・将来分析
・血管性認知症治療の種類別セグメント：治療、機器介入
・血管性認知症治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・血管性認知症治療の用途別セグメント：病院、診療所、リハビリセンター、その他
・血管性認知症治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の血管性認知症治療市場
・企業別のグローバル血管性認知症治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の血管性認知症治療の年間売上：2018-2023年の売上、市場シェア
・企業別の血管性認知症治療販売価格
・主要企業の血管性認知症治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

血管性認知症治療の地域別レビュー
・地域別の血管性認知症治療市場規模2018-2023：年間販売量、売上
・主要国別の血管性認知症治療市場規模2018-2023：年間販売量、売上
・南北アメリカの血管性認知症治療販売の成長
・アジア太平洋の血管性認知症治療販売の成長
・ヨーロッパの血管性認知症治療販売の成長
・中東・アフリカの血管性認知症治療販売の成長

南北アメリカ市場
・南北アメリカの国別の血管性認知症治療販売量、売上（2018-2023）
・南北アメリカの血管性認知症治療の種類別販売量
・南北アメリカの血管性認知症治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の血管性認知症治療販売量、売上（2018-2023）
・アジア太平洋の血管性認知症治療の種類別販売量
・アジア太平洋の血管性認知症治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の血管性認知症治療販売量、売上（2018-2023）
・ヨーロッパの血管性認知症治療の種類別販売量
・ヨーロッパの血管性認知症治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の血管性認知症治療販売量、売上（2018-2023）
・中東・アフリカの血管性認知症治療の種類別販売量
・中東・アフリカの血管性認知症治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・血管性認知症治療の製造コスト構造分析
・血管性認知症治療の製造プロセス分析
・血管性認知症治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・血管性認知症治療の主要なグローバル販売業者
・血管性認知症治療の主要なグローバル顧客

地域別の血管性認知症治療市場予測レビュー
・地域別の血管性認知症治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・血管性認知症治療の種類別市場規模予測
・血管性認知症治療の用途別市場規模予測

主要企業分析
Eisai、 Pfizer、 Teva、 Novartis、 Apotex、 Dr Reddy's Laboratories、 Sun Pharmaceutical、 Hansoh Pharma、 Cipla、 BCG Matrix、 PESTLE Analysis、 SWOT Analysis、 Porter’s five forces、 Market Entry Strategies, Inc.、 Ever Neuro Pharma GmbH、 Geny Research Corp.、 Johnson & Johnson
・企業情報
・血管性認知症治療製品
・血管性認知症治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Vascular Dementia Treatment market size is projected to grow from US$ 4548.9 million in 2022 to US$ 6480.9 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.
United States market for Vascular Dementia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vascular Dementia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vascular Dementia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vascular Dementia Treatment players cover Eisai, Pfizer, Teva, Novartis, Apotex, Dr Reddy’s Laboratories, Sun Pharmaceutical, Hansoh Pharma and Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Vascular dementia refers to changes to memory, thinking, and behavior resulting from conditions that affect the blood vessels in the brain. Cognition and brain function can be significantly affected by the size, location, and number of vascular changes.
LPI (LP Information)’ newest research report, the “Vascular Dementia Treatment Industry Forecast” looks at past sales and reviews total world Vascular Dementia Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Vascular Dementia Treatment sales for 2023 through 2029. With Vascular Dementia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vascular Dementia Treatment industry.
This Insight Report provides a comprehensive analysis of the global Vascular Dementia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vascular Dementia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vascular Dementia Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vascular Dementia Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vascular Dementia Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Vascular Dementia Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Medical Treatement
Device Intervention
Segmentation by application
Hospitals and Clinics
Rehabilitation Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Eisai
Pfizer
Teva
Novartis
Apotex
Dr Reddy’s Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
BCG Matrix
PESTLE Analysis
SWOT Analysis
Porter’s five forces
Market Entry Strategies, Inc.
Ever Neuro Pharma GmbH
Geny Research Corp.
Johnson & Johnson
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vascular Dementia Treatment market?
What factors are driving Vascular Dementia Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vascular Dementia Treatment market opportunities vary by end market size?
How does Vascular Dementia Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vascular Dementia Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vascular Dementia Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vascular Dementia Treatment by Country/Region, 2018, 2022 & 2029
2.2 Vascular Dementia Treatment Segment by Type
2.2.1 Medical Treatement
2.2.2 Device Intervention
2.3 Vascular Dementia Treatment Sales by Type
2.3.1 Global Vascular Dementia Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Vascular Dementia Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vascular Dementia Treatment Sale Price by Type (2018-2023)
2.4 Vascular Dementia Treatment Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Rehabilitation Centers
2.4.3 Others
2.5 Vascular Dementia Treatment Sales by Application
2.5.1 Global Vascular Dementia Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Vascular Dementia Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vascular Dementia Treatment Sale Price by Application (2018-2023)
3 Global Vascular Dementia Treatment by Company
3.1 Global Vascular Dementia Treatment Breakdown Data by Company
3.1.1 Global Vascular Dementia Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Vascular Dementia Treatment Sales Market Share by Company (2018-2023)
3.2 Global Vascular Dementia Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Vascular Dementia Treatment Revenue by Company (2018-2023)
3.2.2 Global Vascular Dementia Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Vascular Dementia Treatment Sale Price by Company
3.4 Key Manufacturers Vascular Dementia Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vascular Dementia Treatment Product Location Distribution
3.4.2 Players Vascular Dementia Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vascular Dementia Treatment by Geographic Region
4.1 World Historic Vascular Dementia Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Vascular Dementia Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vascular Dementia Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vascular Dementia Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Vascular Dementia Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vascular Dementia Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vascular Dementia Treatment Sales Growth
4.4 APAC Vascular Dementia Treatment Sales Growth
4.5 Europe Vascular Dementia Treatment Sales Growth
4.6 Middle East & Africa Vascular Dementia Treatment Sales Growth
5 Americas
5.1 Americas Vascular Dementia Treatment Sales by Country
5.1.1 Americas Vascular Dementia Treatment Sales by Country (2018-2023)
5.1.2 Americas Vascular Dementia Treatment Revenue by Country (2018-2023)
5.2 Americas Vascular Dementia Treatment Sales by Type
5.3 Americas Vascular Dementia Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vascular Dementia Treatment Sales by Region
6.1.1 APAC Vascular Dementia Treatment Sales by Region (2018-2023)
6.1.2 APAC Vascular Dementia Treatment Revenue by Region (2018-2023)
6.2 APAC Vascular Dementia Treatment Sales by Type
6.3 APAC Vascular Dementia Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vascular Dementia Treatment by Country
7.1.1 Europe Vascular Dementia Treatment Sales by Country (2018-2023)
7.1.2 Europe Vascular Dementia Treatment Revenue by Country (2018-2023)
7.2 Europe Vascular Dementia Treatment Sales by Type
7.3 Europe Vascular Dementia Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vascular Dementia Treatment by Country
8.1.1 Middle East & Africa Vascular Dementia Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vascular Dementia Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Vascular Dementia Treatment Sales by Type
8.3 Middle East & Africa Vascular Dementia Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vascular Dementia Treatment
10.3 Manufacturing Process Analysis of Vascular Dementia Treatment
10.4 Industry Chain Structure of Vascular Dementia Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vascular Dementia Treatment Distributors
11.3 Vascular Dementia Treatment Customer
12 World Forecast Review for Vascular Dementia Treatment by Geographic Region
12.1 Global Vascular Dementia Treatment Market Size Forecast by Region
12.1.1 Global Vascular Dementia Treatment Forecast by Region (2024-2029)
12.1.2 Global Vascular Dementia Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vascular Dementia Treatment Forecast by Type
12.7 Global Vascular Dementia Treatment Forecast by Application
13 Key Players Analysis
13.1 Eisai
13.1.1 Eisai Company Information
13.1.2 Eisai Vascular Dementia Treatment Product Portfolios and Specifications
13.1.3 Eisai Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Eisai Main Business Overview
13.1.5 Eisai Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Vascular Dementia Treatment Product Portfolios and Specifications
13.2.3 Pfizer Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Vascular Dementia Treatment Product Portfolios and Specifications
13.3.3 Teva Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Vascular Dementia Treatment Product Portfolios and Specifications
13.4.3 Novartis Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Apotex
13.5.1 Apotex Company Information
13.5.2 Apotex Vascular Dementia Treatment Product Portfolios and Specifications
13.5.3 Apotex Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Apotex Main Business Overview
13.5.5 Apotex Latest Developments
13.6 Dr Reddy’s Laboratories
13.6.1 Dr Reddy’s Laboratories Company Information
13.6.2 Dr Reddy’s Laboratories Vascular Dementia Treatment Product Portfolios and Specifications
13.6.3 Dr Reddy’s Laboratories Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Dr Reddy’s Laboratories Main Business Overview
13.6.5 Dr Reddy’s Laboratories Latest Developments
13.7 Sun Pharmaceutical
13.7.1 Sun Pharmaceutical Company Information
13.7.2 Sun Pharmaceutical Vascular Dementia Treatment Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sun Pharmaceutical Main Business Overview
13.7.5 Sun Pharmaceutical Latest Developments
13.8 Hansoh Pharma
13.8.1 Hansoh Pharma Company Information
13.8.2 Hansoh Pharma Vascular Dementia Treatment Product Portfolios and Specifications
13.8.3 Hansoh Pharma Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hansoh Pharma Main Business Overview
13.8.5 Hansoh Pharma Latest Developments
13.9 Cipla
13.9.1 Cipla Company Information
13.9.2 Cipla Vascular Dementia Treatment Product Portfolios and Specifications
13.9.3 Cipla Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cipla Main Business Overview
13.9.5 Cipla Latest Developments
13.10 BCG Matrix
13.10.1 BCG Matrix Company Information
13.10.2 BCG Matrix Vascular Dementia Treatment Product Portfolios and Specifications
13.10.3 BCG Matrix Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BCG Matrix Main Business Overview
13.10.5 BCG Matrix Latest Developments
13.11 PESTLE Analysis
13.11.1 PESTLE Analysis Company Information
13.11.2 PESTLE Analysis Vascular Dementia Treatment Product Portfolios and Specifications
13.11.3 PESTLE Analysis Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 PESTLE Analysis Main Business Overview
13.11.5 PESTLE Analysis Latest Developments
13.12 SWOT Analysis
13.12.1 SWOT Analysis Company Information
13.12.2 SWOT Analysis Vascular Dementia Treatment Product Portfolios and Specifications
13.12.3 SWOT Analysis Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 SWOT Analysis Main Business Overview
13.12.5 SWOT Analysis Latest Developments
13.13 Porter’s five forces
13.13.1 Porter’s five forces Company Information
13.13.2 Porter’s five forces Vascular Dementia Treatment Product Portfolios and Specifications
13.13.3 Porter’s five forces Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Porter’s five forces Main Business Overview
13.13.5 Porter’s five forces Latest Developments
13.14 Market Entry Strategies, Inc.
13.14.1 Market Entry Strategies, Inc. Company Information
13.14.2 Market Entry Strategies, Inc. Vascular Dementia Treatment Product Portfolios and Specifications
13.14.3 Market Entry Strategies, Inc. Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Market Entry Strategies, Inc. Main Business Overview
13.14.5 Market Entry Strategies, Inc. Latest Developments
13.15 Ever Neuro Pharma GmbH
13.15.1 Ever Neuro Pharma GmbH Company Information
13.15.2 Ever Neuro Pharma GmbH Vascular Dementia Treatment Product Portfolios and Specifications
13.15.3 Ever Neuro Pharma GmbH Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Ever Neuro Pharma GmbH Main Business Overview
13.15.5 Ever Neuro Pharma GmbH Latest Developments
13.16 Geny Research Corp.
13.16.1 Geny Research Corp. Company Information
13.16.2 Geny Research Corp. Vascular Dementia Treatment Product Portfolios and Specifications
13.16.3 Geny Research Corp. Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Geny Research Corp. Main Business Overview
13.16.5 Geny Research Corp. Latest Developments
13.17 Johnson & Johnson
13.17.1 Johnson & Johnson Company Information
13.17.2 Johnson & Johnson Vascular Dementia Treatment Product Portfolios and Specifications
13.17.3 Johnson & Johnson Vascular Dementia Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Johnson & Johnson Main Business Overview
13.17.5 Johnson & Johnson Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Vascular Dementia Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vascular Dementia Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Medical Treatement
Table 4. Major Players of Device Intervention
Table 5. Global Vascular Dementia Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Vascular Dementia Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Vascular Dementia Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vascular Dementia Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Vascular Dementia Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Vascular Dementia Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Vascular Dementia Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Vascular Dementia Treatment Revenue by Application (2018-2023)
Table 13. Global Vascular Dementia Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Vascular Dementia Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Vascular Dementia Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Vascular Dementia Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Vascular Dementia Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vascular Dementia Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Vascular Dementia Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Vascular Dementia Treatment Producing Area Distribution and Sales Area
Table 21. Players Vascular Dementia Treatment Products Offered
Table 22. Vascular Dementia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vascular Dementia Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Vascular Dementia Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vascular Dementia Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vascular Dementia Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vascular Dementia Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Vascular Dementia Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vascular Dementia Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vascular Dementia Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vascular Dementia Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Vascular Dementia Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Vascular Dementia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vascular Dementia Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Vascular Dementia Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Vascular Dementia Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Vascular Dementia Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Vascular Dementia Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Vascular Dementia Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vascular Dementia Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Vascular Dementia Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Vascular Dementia Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Vascular Dementia Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Vascular Dementia Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Vascular Dementia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vascular Dementia Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Vascular Dementia Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Vascular Dementia Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Vascular Dementia Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Vascular Dementia Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vascular Dementia Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vascular Dementia Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vascular Dementia Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Vascular Dementia Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vascular Dementia Treatment
Table 58. Key Market Challenges & Risks of Vascular Dementia Treatment
Table 59. Key Industry Trends of Vascular Dementia Treatment
Table 60. Vascular Dementia Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vascular Dementia Treatment Distributors List
Table 63. Vascular Dementia Treatment Customer List
Table 64. Global Vascular Dementia Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Vascular Dementia Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vascular Dementia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Vascular Dementia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vascular Dementia Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Vascular Dementia Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vascular Dementia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Vascular Dementia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vascular Dementia Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Vascular Dementia Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vascular Dementia Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Vascular Dementia Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vascular Dementia Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Vascular Dementia Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Eisai Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Eisai Vascular Dementia Treatment Product Portfolios and Specifications
Table 80. Eisai Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Eisai Main Business
Table 82. Eisai Latest Developments
Table 83. Pfizer Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Vascular Dementia Treatment Product Portfolios and Specifications
Table 85. Pfizer Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Teva Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Vascular Dementia Treatment Product Portfolios and Specifications
Table 90. Teva Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Teva Main Business
Table 92. Teva Latest Developments
Table 93. Novartis Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Vascular Dementia Treatment Product Portfolios and Specifications
Table 95. Novartis Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Apotex Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Apotex Vascular Dementia Treatment Product Portfolios and Specifications
Table 100. Apotex Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Apotex Main Business
Table 102. Apotex Latest Developments
Table 103. Dr Reddy's Laboratories Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Dr Reddy's Laboratories Vascular Dementia Treatment Product Portfolios and Specifications
Table 105. Dr Reddy's Laboratories Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Dr Reddy's Laboratories Main Business
Table 107. Dr Reddy's Laboratories Latest Developments
Table 108. Sun Pharmaceutical Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Sun Pharmaceutical Vascular Dementia Treatment Product Portfolios and Specifications
Table 110. Sun Pharmaceutical Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sun Pharmaceutical Main Business
Table 112. Sun Pharmaceutical Latest Developments
Table 113. Hansoh Pharma Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Hansoh Pharma Vascular Dementia Treatment Product Portfolios and Specifications
Table 115. Hansoh Pharma Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Hansoh Pharma Main Business
Table 117. Hansoh Pharma Latest Developments
Table 118. Cipla Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Cipla Vascular Dementia Treatment Product Portfolios and Specifications
Table 120. Cipla Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Cipla Main Business
Table 122. Cipla Latest Developments
Table 123. BCG Matrix Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. BCG Matrix Vascular Dementia Treatment Product Portfolios and Specifications
Table 125. BCG Matrix Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. BCG Matrix Main Business
Table 127. BCG Matrix Latest Developments
Table 128. PESTLE Analysis Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. PESTLE Analysis Vascular Dementia Treatment Product Portfolios and Specifications
Table 130. PESTLE Analysis Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. PESTLE Analysis Main Business
Table 132. PESTLE Analysis Latest Developments
Table 133. SWOT Analysis Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. SWOT Analysis Vascular Dementia Treatment Product Portfolios and Specifications
Table 135. SWOT Analysis Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. SWOT Analysis Main Business
Table 137. SWOT Analysis Latest Developments
Table 138. Porter’s five forces Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 139. Porter’s five forces Vascular Dementia Treatment Product Portfolios and Specifications
Table 140. Porter’s five forces Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Porter’s five forces Main Business
Table 142. Porter’s five forces Latest Developments
Table 143. Market Entry Strategies, Inc. Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 144. Market Entry Strategies, Inc. Vascular Dementia Treatment Product Portfolios and Specifications
Table 145. Market Entry Strategies, Inc. Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Market Entry Strategies, Inc. Main Business
Table 147. Market Entry Strategies, Inc. Latest Developments
Table 148. Ever Neuro Pharma GmbH Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 149. Ever Neuro Pharma GmbH Vascular Dementia Treatment Product Portfolios and Specifications
Table 150. Ever Neuro Pharma GmbH Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Ever Neuro Pharma GmbH Main Business
Table 152. Ever Neuro Pharma GmbH Latest Developments
Table 153. Geny Research Corp. Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 154. Geny Research Corp. Vascular Dementia Treatment Product Portfolios and Specifications
Table 155. Geny Research Corp. Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Geny Research Corp. Main Business
Table 157. Geny Research Corp. Latest Developments
Table 158. Johnson & Johnson Basic Information, Vascular Dementia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 159. Johnson & Johnson Vascular Dementia Treatment Product Portfolios and Specifications
Table 160. Johnson & Johnson Vascular Dementia Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Johnson & Johnson Main Business
Table 162. Johnson & Johnson Latest Developments
List of Figures
Figure 1. Picture of Vascular Dementia Treatment
Figure 2. Vascular Dementia Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vascular Dementia Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Vascular Dementia Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vascular Dementia Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Medical Treatement
Figure 10. Product Picture of Device Intervention
Figure 11. Global Vascular Dementia Treatment Sales Market Share by Type in 2022
Figure 12. Global Vascular Dementia Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Vascular Dementia Treatment Consumed in Hospitals and Clinics
Figure 14. Global Vascular Dementia Treatment Market: Hospitals and Clinics (2018-2023) & (K Units)
Figure 15. Vascular Dementia Treatment Consumed in Rehabilitation Centers
Figure 16. Global Vascular Dementia Treatment Market: Rehabilitation Centers (2018-2023) & (K Units)
Figure 17. Vascular Dementia Treatment Consumed in Others
Figure 18. Global Vascular Dementia Treatment Market: Others (2018-2023) & (K Units)
Figure 19. Global Vascular Dementia Treatment Sales Market Share by Application (2022)
Figure 20. Global Vascular Dementia Treatment Revenue Market Share by Application in 2022
Figure 21. Vascular Dementia Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Vascular Dementia Treatment Sales Market Share by Company in 2022
Figure 23. Vascular Dementia Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Vascular Dementia Treatment Revenue Market Share by Company in 2022
Figure 25. Global Vascular Dementia Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Vascular Dementia Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Vascular Dementia Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Vascular Dementia Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Vascular Dementia Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Vascular Dementia Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Vascular Dementia Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Vascular Dementia Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Vascular Dementia Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Vascular Dementia Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Vascular Dementia Treatment Sales Market Share by Country in 2022
Figure 36. Americas Vascular Dementia Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Vascular Dementia Treatment Sales Market Share by Type (2018-2023)
Figure 38. Americas Vascular Dementia Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Vascular Dementia Treatment Sales Market Share by Region in 2022
Figure 44. APAC Vascular Dementia Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Vascular Dementia Treatment Sales Market Share by Type (2018-2023)
Figure 46. APAC Vascular Dementia Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Vascular Dementia Treatment Sales Market Share by Country in 2022
Figure 55. Europe Vascular Dementia Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Vascular Dementia Treatment Sales Market Share by Type (2018-2023)
Figure 57. Europe Vascular Dementia Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Vascular Dementia Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Vascular Dementia Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Vascular Dementia Treatment Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Vascular Dementia Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Vascular Dementia Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Vascular Dementia Treatment in 2022
Figure 73. Manufacturing Process Analysis of Vascular Dementia Treatment
Figure 74. Industry Chain Structure of Vascular Dementia Treatment
Figure 75. Channels of Distribution
Figure 76. Global Vascular Dementia Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Vascular Dementia Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Vascular Dementia Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Vascular Dementia Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Vascular Dementia Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Vascular Dementia Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の血管性認知症治療市場予測 2023年-2029年] (コード：LP23DC08715)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血管性認知症治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の認知症用錠剤ディスペンサー市場予測 2023年-2029年
  • 世界の動脈血管バイオプロテーゼ市場予測 2023年-2029年
  • 世界の血管吻合ホイール市場予測 2023年-2029年
  • 世界の血液透析用バスキュラーアクセスデバイス市場予測 2023年-2029年
  • 世界の筋骨格系腫瘍治療市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆